Data from both companies’ mid-stage trials were released Saturday at the annual meeting of the American Association for the Study of Liver Disease in Boston. Gilead’s study, dubbed Electron, examined 25 patients with genotype 1 chronic hepatitis C virus (HCV) infection who were treated for 12 weeks with a combination of three drugs: sofosbuvir, ribavirin and GS-5885.
GS-5885 is from a promising new class of drugs known as NS5A inhibitors, which prevent the hepatitis C virus from replicating.
Sofosbuvir and GS-5885 are still being studied for their safety and efficacy.
Will this untested drug in combination with another untested drug potentially cause other health issues. The immediate image that came to mind was the scene from that movie “Serenity” when the lone crew discovered that the reason the ravers existed was because the drug that was created to cure man from “himself” actually had a deadly side effect that caused those tested-to revert back to animalistic characteristics.
Ok so my imagination gets the best of me sometimes but it is widely held that many of the science fiction movies created are widely prophetic and/or based in the scientific dark side that many of us are not privy to knowing.